Parenteral Nutrition Market Size To Reach $12.59 Billion By 2033

March 2026 | Report Format: Electronic (PDF)

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 12.59 billion by 2033, registering a CAGR of 5.87% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.

The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.

Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.


key Request a free sample copy or view report summary: Parenteral Nutrition Market Report


Parenteral Nutrition Market Report Highlights

  • By nutrient type, the single-dose amino acid solution segment accounted for the largest market share of 30.56% in 2025. The parenteral lipid emulsion segment is anticipated to register the fastest CAGR growth of 6.44% during the forecast period.

  • By stage type, the adult segment held the largest market share in 2025. The pediatric segment is anticipated to witness high growth owing to increased consumption of parenteral nutrition among preterm neonates in their initial life after birth.

  • By indication type, the cancer care segment dominated the market in 2025. However, the dysphagia segment is anticipated to witness the fastest growth rate over the forecast period due to its rising prevalence.

  • By sales channel, the institutional sales channel segment dominated the market with a share in 2025. The online sales channel is expected to witness the fastest growth rate owing to a shift in the trend toward direct selling to customers via e-commerce platforms.

  • North America dominated the global parenteral nutrition market with the largest revenue share of 42.26% in 2025. The parenteral nutrition market in the U.S. held the largest revenue share in 2025.

  • The parenteral nutrition market in the Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

Parenteral Nutrition Market Segmentation

Grand View Research has segmented global parenteral nutrition market report based on nutrient type, stage type, indication, sales channel, and region:

Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Carbohydrates

  • Parenteral Lipid Emulsion

  • Single Dose Amino Acid Solution

  • Trace Elements

  • Vitamins & Minerals

Parenteral Nutrition Stage Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Adult

  • Pediatrics

Parenteral Nutrition Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

Parenteral Nutrition Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Online

  • Retail

  • Institutional

Parenteral Nutrition Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
    • U.S.
    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • India

    • Japan

    • Thailand

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players of Parenteral Nutrition Market

  • Baxter

  • Otsuka Pharmaceutical Factory, Inc.

  • Grifols, S.A.

  • B. Braun Melsungen AG

  • Vifor Pharma (Acquired by CSL)

  • Fresenius Kabi AG

  • Sichuan Kelun Pharmaceutical Co., Ltd.

  • Pfizer Inc. (Hospira Inc.)

  • ICU Medical, Inc.

  • JW Pharmaceutical

  • Aculife

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization